source
- OrbiMed raises $3 billion, its biggest Asian fund yet, to boost biotech investments worldwideOrbiMed announced it has closed a $3 billion fundraising round, the largest ever for its Asia‑focused vehicle. The capital will be used to make new growth‑equity and venture investments in biotech…
- Nvidia-backed Iambic Therapeutics raises $150M in IPO, begins trading ThursdayIambic Therapeutics, a biotech focused on using artificial intelligence to develop cancer treatments, announced the completion of its initial public offering. The company sold 9.38 million shares…